Retinoids regulate survival and antigen presentation by immature dendritic cells

Journal of Experimental Medicine

Volumn 198, Issue 4, 2003, Pages 623-634

  Geissmann, Frédéric ^a,b,c   Revy, Patrick ^c   Brousse, Nicole ^a   Lepelletier, Yves ^b   Folli, Claudia ^d   Durandy, Anne ^c   Chambon, Pierre ^e   Dy, Michel ^b  

^a UPRES EA 219   (France)

^b CNRS   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF PARMA   (Italy)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Antigen presentation; Cellular activation; Human; Immunomodulators; Nuclear receptors

Indexed keywords

4 [2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1,3 DIOXOLAN 2 YL]BENZOIC ACID; BMS 453; BMS 493; BMS 614; BMS 641; BMS 749; BMS 753; BMS 961; CELL NUCLEUS RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINOID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BINDING KINETICS; CELL ACTIVATION; CELL KINETICS; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; DISSOCIATION CONSTANT; DNA BINDING; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD86; APOPTOSIS; CASPASES; CD40 LIGAND; CELL SURVIVAL; CELLS, CULTURED; DENDRITIC CELLS; DIMERIZATION; DNA-BINDING PROTEINS; GENES, MHC CLASS II; HLA ANTIGENS; HUMANS; MEMBRANE GLYCOPROTEINS; NUCLEAR PROTEINS; RECEPTORS, RETINOIC ACID; RETINOIDS; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042922808     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030390     Document Type: Article

References (46)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
2. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940-954.
3. Buck, J., F. Derguini, E. Levi, K. Nakanishi, and U. Hammerling. 1991. Intracellular signaling by 14-hydroxy-4,14-retro-retinol. Science. 254:1654-1656.
4. Malkovsky, M., A.J. Edwards, R. Hunt, L. Palmer, and P.B. Medawar. 1983. T-cell-mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched in vitamin A acetate. Nature. 302:338-340.
5. Malkovsky, M., C. Dore, R. Hunt, L. Palmer, P. Chandler, and P.B. Medawar. 1983. Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate. Proc. Natl. Acad. Sci. USA. 80:6322-6326.
6. Malkovsky, M., R. Hunt, L. Palmer, C. Dore, and P.B. Medawar. 1984. Retinyl acetate-mediated augmentation of resistance to a transplantable 3-methylcholanthrene-induced fibrosarcoma. The dose response and time course. Transplantation. 38:158-161.
7. Malkovsky, M., P.B. Medawar, D.R. Thatcher, J. Toy, R. Hunt, L.S. Rayfield, and C. Dore. 1985. Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc. Natl. Acad. Sci. USA. 82:536-538.
8. Ross, A.C., and C.B. Stephensen. 1996. Vitamin A and retinoids in antiviral responses. FASEB J. 10:979-985.
9. Rahmathullah, L., B.A. Underwood, R.D. Thulasiraj, R.C. Milton, K. Ramaswamy, R. Rahmathullah, and G. Babu. 1990. Reduced mortality among children in southern India receiving a small weekly dose of vitamin A. N. Engl. J. Med. 323:929-935.
10. Semba, R.D. 1994. Vitamin A, immunity, and infection. Clin. Infect. Dis. 19:489-499.
11. Sommer, A. 1992. Vitamin A deficiency and childhood mortality. Lancet. 340:488-489.
12. Underwood, B.A., and P. Arthur. 1996. The contribution of vitamin A to public health. FASEB J. 10:1040-1048.
13. Buck, J., A. Myc, A. Garbe, and G. Cathomas. 1991. Differences in the action and metabolism between retinol and retinoic acid in B lymphocytes. J. Cell Biol. 115:851-859.
14. Garbe, A., J. Buck, and U. Hammerling. 1992. Retinoids are important cofactors in T cell activation. J. Exp. Med. 176:109-117.
15. Yang, Y., M.S. Vacchio, and J.D. Ashwell. 1993. 9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc. Natl. Acad. Sci. USA. 90:6170-6174.
16. Bissonnette, R.P., T. Brunner, S.B. Lazarchik, N.J. Yoo, M.F. Boehm, D.R. Green, and R.A. Heyman. 1995. 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol. Cell. Biol. 15:5576-5585.
17. Katz, D.R., M. Drzymala, J.A. Turton, R.M. Hicks, R. Hunt, L. Palmer, and M. Malkovsky. 1987. Regulation of accessory cell function by retinoids in murine immune responses. Br. J. Exp. Pathol. 68:343-350.
18. Meunier, L., K. Bohjanen, J.J. Voorhees, and K.D. Cooper. 1994. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. J. Invest. Dermatol. 103:775-779.
19. Bedford, P.A., and S.C. Knight. 1989. The effect of retinoids on dendritic cell function. Clin. Exp. Immunol. 75:481-486.
20. Hachisuka, H., and H. Uno. 1987. Effects of retinoic acid on the epidermal Langerhans cells and beta-glucuronidase activity in macaque skin. Am. J. Dermatopathol. 9:316-323.
21. Semba, R.D., Z. Munasir, J. Beeler, A. Akib, Muhilal, S. Audet, and A. Sommer. 1995. Reduced seroconversion to measles in infants given vitamin A with measles vaccination. Lancet. 345:1330-1332.
22. Walsh, L.J., G.J. Seymour, and R.N. Powell. 1985. The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production. J. Invest. Dermatol. 85:501-506.
23. Williams, N.A., and T.J. Hill. 1991. Effects on murine epidermal Langerhans cells of drugs known to cause recrudescent herpes simplex virus infection in a mouse model. J. Invest. Dermatol. 97:933-937.
24. Geissmann, F., C. Prost, J.P. Monnet, M. Dy, N. Brousse, and O. Hermine. 1998. Transforming growth Factor β 1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J. Exp. Med. 187:961-966.
25. Geissmann, F., P. Revy, A. Regnault, Y. Lepelletier, M. Dy, N. Brousse, S. Amigorena, O. Hermine, and A. Durandy. 1999. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 162:4567-4575.
26. Chazaud, C., P. Chambon, and P. Dolle. 1999. Retinoic acid is required in the mouse embryo for left-right asymmetry determination and heart morphogenesis. Development. 126:2589-2596.
27. Chen, J.Y., S. Penco, J. Ostrowski, P. Balaguer, M. Pons, J.E. Starrett, P. Reczek, P. Chambon, and H. Gronemeyer. 1995. RAR-specific agonist/ antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14:1187-1197.
28. Chen, J.Y., J. Clifford, C. Zusi, J. Starrett, D. Tortolani, J. Ostrowski, P.R. Reczek, P. Chambon, and H. Gronemeyer. 1996. Two distinct actions of retinoid-receptor ligands. Nature. 382:819-822.
29. Lehmann, J.M., L. Jong, A. Fanjul, J.F. Cameron, X.P. Lu, P. Haefner, M.I. Dawson, and M. Pfahl. 1992. Retinoids selective for retinoid X receptor response pathways. Science. 258:1944-1946.
30. Taneja, R., B. Roy, J.L. Plassar, C.F. Zusi, J. Ostrowski, P.R. Reczek, and P. Chambon. 1996. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Natl. Acad. Sci. USA. 93:6197-6202.
31. Malpeli, G., C. Folli, and R. Berni. 1996. Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin. Biochim. Biophys. Acta. 1294:48-54.
32. Valladeau, J., V. Duvert-Frances, J.J. Pin, C. Dezutter-Dambuyant, C. Vincent, C. Massacrier, J. Vincent, K. Yoneda, J. Banchereau, C. Caux, et al. 1999. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29:2695-2704.
33. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 12:71-81.
34. Vivat, V., C. Zechel, J.M. Wurtz, W. Bourguet, H. Kagechika, H. Umemiya, K. Shudo, D. Moras, H. Gronemeyer, and P. Chambon. 1997. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J. 16:5697-5709.
35. Roake, J.A., A.S. Rao, P.J. Morris, C.P. Larsen, D.F. Hankins, and J.M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
36. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400.
37. Epstein, S.P., R.L. Baer, G.J. Thorbecke, and D.V. Belsito. 1991. Immunosuppressive effects of transforming growth factor beta: inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response. J. Invest. Dermatol. 96:832-837.
38. Geissmann, F., M.C. Dieu-Nosjean, C. Dezutter, J. Valladeau, S. Kayal, M. Leborgne, N. Brousse, S. Saeland, and J. Davoust. 2002. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196:417-430.
39. Rescigno, M., M. Martino, C.L. Sutherland, M.R. Gold, and P. Ricciardi-Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188:2175-2180.
40. Ridge, J.P., F. Di Rosa, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 393:474-478.
41. Benoit, G., L. Altucci, M. Flexor, S. Ruchaud, J. Lillehaug, W. Raffelsberger, H. Gronemeyer, and M. Lanotte. 1999. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J. 18:7011-7018.
42. Munger, J.S., X. Huang, H. Kawakatsu, M.J. Griffiths, S.L. Dalton, J. Wu, J.F. Pittet, N. Kaminski, C. Garat, M.A. Matthay, et al. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:319-328.
43. Borkowski, T.A., J.J. Letterio, A.G. Farr, and M.C. Udey. 1996. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta I null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184:2417-2422.
44. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-1118.
45. Forman, B.M., P. Tontonoz, J. Chen, R.P. Brun, B.M. Spiegelman, and R.M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83:803-812.
46. Mangelsdorf, D.J., and R.M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell. 83:841-850.